Rontalizumab

Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
Read more
€0.00 (tax incl.)
Reference:
HY-P99267
Product Details
HY-P99267

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
COVID-19-immunoregulation
CAS
948570-30-7

Menu

Settings